Reactive oxygen species accelerated glycation for oxygen-independent corneal cross-linking
Frontiers in Bioengineering and Biotechnology · 31.03.2026 · 14
DOI: 10.3389/fbioe.2026.1695384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 31.03.2026. Verfasst von Jiashuai Fan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, Columbia University, New York, NY, United States. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The pentose-initiated Maillard reaction may serve as an oxygen-independent, non-enzymatic crosslinking (CxL) mechanism, but its slow kinetics limit clinical applicability. We hypothesize that glycation-mediated CxL can be accelerated by reactive oxygen species (ROS), potentially enabling its use in the treatment of keratoconus.
Methods
Rabbit corneal buttons were exposed to 20% ribose and irradiated with femtosecond oscillator laser pulses at 450 mW (1,069 nm) and 250 mW (400 nm). In addition to laser-based light sources, a 365 nm UVA lamp at 3 mW/cm 2 was used in combination with either ribose or riboflavin-5-phosphate to generate comparison and control groups. ROS-Glycation-CxLed corneas were flattened with a glass coverslip to minimize oxygen replenishment. Crosslinking efficacy was assessed using 5 µm micro-indentation to measure the equilibrium modulus and viscoelastic ratio post-treatment.
Results
Corneal tissues subjected to ROS-glycation-CxL exhibited a significant increase in equilibrium modulus. The modulus change in ribose-exposed tissues treated with UVA light was comparable to that observed with the conventional UVA–riboflavin CxL pathway. In contrast, infrared and blue laser-treated samples showed less stiffening, likely due to the limited tissue volume affected by the laser’s focal region. Notably, only the UVA–riboflavin-treated tissues demonstrated a pronounced elastic load-relaxation response.
Conclusion
ROS-Glycation-CxL offers a potential alternative to existing crosslinking techniques, with crucial advantages such as reduced oxygen reliance, light-source agnostic mechanism, and customizable treatment patterns with laser light sources. Further investigation is needed to evaluate the clinical viability of ROS-glycation CxL through optimization of sugar concentration, treatment duration, and assessment of stromal extracellular matrix ultrastructure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, Columbia University, New York, NY, United States.
Zitieren
APA
Fan, J., & Vukelic, S. (2026). Reactive oxygen species accelerated glycation for oxygen-independent corneal cross-linking. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1695384
Vancouver
Fan J, Vukelic S. Reactive oxygen species accelerated glycation for oxygen-independent corneal cross-linking. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1695384
BibTeX
@article{Fan2026,
author = {Fan, Jiashuai and Vukelic, Sinisa},
title = {Reactive oxygen species accelerated glycation for oxygen-independent corneal cross-linking},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1695384}
}
EUVIMED